基于人工智能的临床前疾病风险评估,使用英国生物库中的成像
Dmitrii Seletkov1,2, Sophie Starck3, Tamara T Mueller3
1Institute of Diagnostic and Interventional Radiology, Technical University of Munich School of Medicine, Munich, Germany. dmitrii.seletkov@tum.de.
NPJ digital medicine
|July 27, 2025
概括
与人工智能集成的全身磁共振成像 (MRI) 可以预测疾病风险. 来自MRI的图像衍生放射学特性为各种条件提供了卓越的预测性能.
科学领域:
- 医疗成像医学成像
- 人工智能的人工智能
- 无线电学 (Radiomics) 是一种无线电学.
- 疾病风险预测 疾病风险预测
背景情况:
- 早期发现疾病对于干预和改善患者结果至关重要.
- 医学成像提供客观数据,与主观的自我报告信息不同.
- 人工智能 (AI) 越来越多地用于风险评估,但医学成像的潜力未得到充分利用.
研究的目的:
- 展示全身MRI整合到疾病风险评估的常规查工作流程中.
- 评估基于人工智能的管道,用于处理全身MRI数据.
- 评估图像衍生放射学特征对预测广泛疾病的有用性.
主要方法:
- 利用来自英国生物银行前性研究的至膝盖全身MRI数据.
- 开发和评估基于人工智能的管道,用于处理全身MRI数据.
- 使用图像衍生放射学特征与非图像数据进行比较的预测性能.
主要成果:
- 基于AI的管道有效处理全身MRI数据.
- 图像衍生放射学特征展示了卓越的预测性能.
- 放射学功能提供了更好的解释性和与非图像数据的集成.
结论:
- 全身MRI,当用AI和放射学分析时,显著提高了疾病风险预测.
- 这种方法为心血管,消化,代谢,炎症,退行和瘤疾病的早期检测提供了强大的工具.
- 将全身MRI的放射学整合到临床工作流程中,有望为积极主动的医疗保健提供希望.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
120
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
120